SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$0.21
0.00 (0.39%)
▲
5d:
+1.97%
30d:
-22.76%
90d:
-79.71%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -26.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -26.5% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.21, which is considered slightly low relative to its 30-day fair value range of $0.19 to $0.25. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.4) compared to its historical average (3.5). Remarkably, the market is currently pricing in an annual earnings decline of 26.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.38.
Market Sentiment: SNYR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.75 (+1711.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.38.
Market Sentiment: SNYR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.75 (+1711.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.19 -
$0.25
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1711.6% below Wall St target ($3.75)
Trading Range Analysis
30-Day Trading Range
$0.19 -
$0.25
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.38
Wall Street Target
$3.75
(+1711.6%)
Revenue Growth (YoY)
-32.8%
Earnings Growth (YoY)
-90.6%
Profit Margin
-57.0%
Valuation Discount vs History
-26.5% cheaper
PE vs Historical
1.4 vs 3.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-26.5%
(market-implied from PE analysis)
1-Year Target
$0.19
(-10%)
2-Year Target
$0.17
(-19%)
3-Year Target
$0.15
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→4)
$0.38
(+85%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.4 to 3.5
Stabilization Target:
$0.52
(+153.6%)
PE Expansion Potential:
+153.6%
Share & Embed Analysis
Last updated: July 02, 2026 10:56 PM ET
Data refreshes hourly during market hours. Next update: 11:56 PM
Data refreshes hourly during market hours. Next update: 11:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$941 | 60 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$351 | 64 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$245 | 62 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$88 | 63 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
